These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6411812)

  • 1. Dissociation in expression of MB1/MT1 and DR1 alloantigens in mutants of a lymphoblastoid cell line.
    DeMars R; Chang CC; Marrari M; Duquesnoy RJ; Noreen H; Segall M; Bach FH
    J Immunol; 1983 Sep; 131(3):1318-21. PubMed ID: 6411812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line.
    DeMars R; Chang CC; Rudersdorf RA
    Hum Immunol; 1983 Oct; 8(2):123-39. PubMed ID: 6417067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular, serologic, and functional evidence for an apparent HLA-DR triplet.
    Bontrop RE; Schreuder GM; Elferink DG; Mikulski MM; Geerse R; Giphart MJ
    J Immunol; 1986 Jul; 137(1):211-6. PubMed ID: 3486913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of the human MHC-linked complement genes between HLA-B and HLA-DR by using HLA mutant cell lines.
    Whitehead AS; Colten HR; Chang CC; Demars R
    J Immunol; 1985 Jan; 134(1):641-3. PubMed ID: 3917284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
    Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
    J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for expression of class II MHC public determinants detected by T-cell clones.
    Nikaein A; McQueen K; Gobeli M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):626-7. PubMed ID: 2468225
    [No Abstract]   [Full Text] [Related]  

  • 9. Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen.
    Shackelford DA; Mann DL; van Rood JJ; Ferrara GB; Strominger JL
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4566-70. PubMed ID: 6974868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective antigen presentation and novel structural properties of DR1 from an HLA haplotype associated with 21-hydroxylase deficiency.
    Davis JE; Rich RR; Van M; Le HV; Pollack MS; Cook RG
    J Clin Invest; 1987 Oct; 80(4):998-1008. PubMed ID: 2443540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary structure of human class II histocompatibility antigens (HLA-D). I. Isolation, purification and characterization of the HLA-D alpha/beta chain complex from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2, 2;DR2,2;MT1,1;DC1,1;MB1,1].
    Thinnes FP; Egert G; Götz H; Pauly E; Altevogt P; Kölbel S; Wernet P; Kratzin H; Yang C; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1984 Nov; 365(11):1277-89. PubMed ID: 6334638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC.
    Malnati MS; Ceman S; Weston M; DeMars R; Long EO
    J Immunol; 1993 Dec; 151(12):6751-6. PubMed ID: 8258689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
    Alexander S; Hubbard SC; Strominger JL
    J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed evolution of soluble single-chain human class II MHC molecules.
    Esteban O; Zhao H
    J Mol Biol; 2004 Jun; 340(1):81-95. PubMed ID: 15184024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary structure of human class II histocompatibility antigens (HLA-D). II. Separation of alpha from beta-chains of HLA-D from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2,2;MT1,1;DC1,1;MB1,1), and characterization of the isolated chain].
    Egert G; Thinnes FP; Götz H; Pauly E; Kratzin H; Yang CY; Kölbel S; Altevogt P; Wernet P; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1984 Nov; 365(11):1291-308. PubMed ID: 6334639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HLA-DR by a human monocyte cell line is under transcriptional control.
    Peterlin BM; Gonwa TA; Stobo JD
    J Mol Cell Immunol; 1984; 1(3):191-200. PubMed ID: 6443852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of class II histocompatibility antigens isolated from a human lymphoblastoid B cell line homozygous at the HLA loci (HLA-A3, 3; B7, 7; Dw2, 2; DR2,2; DC1,1; MB1,1; MT1,1).
    Kratzin H; Yang CY; Götz H; Thinnes FP; Kruse T; Egert G; Pauly E; Kölbel S; Wernet P; Hilschmann N
    Hum Immunol; 1983 Sep; 8(1):65-73. PubMed ID: 6415000
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of the HLA-DRw9 antigen using two-dimensional gel electrophoresis and alloantisera.
    Yabe T; Suzuki M; Mukai R; Satake M; Juji T; Hamaguchi H
    Jinrui Idengaku Zasshi; 1984 Mar; 29(1):17-25. PubMed ID: 6205188
    [No Abstract]   [Full Text] [Related]  

  • 20. Revertants from the HLA class II regulatory mutant 6.1.6: implications for the regulation of Ia gene expression.
    Levine F; Pious D
    J Immunol; 1984 Feb; 132(2):959-62. PubMed ID: 6418815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.